{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:15:55Z","timestamp":1777378555510,"version":"3.51.4"},"reference-count":14,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Anaesth Intensive Care"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:p>This case report describes a patient who developed allergic contact dermatitis to a chlorhexidine skin preparation applied for a transversus abdominis plane block, but not to a different chlorhexidine solution applied to the surgical field. The patient had presented for an elective inguinal hernia repair. He had a known history of anaphylaxis to non-steroidal anti-inflammatory medication but was otherwise well. The surgery was completed uneventfully. Three or four days postoperatively, the patient developed a rash at the site where chlorhexidine skin preparation had been used to prepare the skin for the transversus abdominis plane block. The rash had well-demarcated edges and exactly matched the distribution of the previously applied skin preparation. No rash was present at the surgical site, which had been prepared with a different chlorhexidine-containing solution. The rash gradually resolved over several weeks with the application of topical corticosteroids. The patient was otherwise completely well with no evidence of infection or any other systemic illness. The skin preparations differed in the dyes and alcohols that they contained. The dyes or alcohol in the preparation for the transversus abdominis plane block were therefore considered the likely cause of this patient\u2019s allergic reaction. Dyes and alcohols should be considered as a cause of skin allergy in the perioperative setting.<\/jats:p>","DOI":"10.1177\/0310057x20973046","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T01:38:23Z","timestamp":1611797903000},"page":"70-73","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Allergic contact dermatitis to a dye or alcohol in a chlorhexidine-based skin preparation: A case report"],"prefix":"10.1177","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6838-7673","authenticated-orcid":false,"given":"Alexandra L","family":"Carle","sequence":"first","affiliation":[{"name":"Department of Anaesthesia and Pain Medicine, Royal Perth Hospital, Perth, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W","family":"Martyr","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia and Pain Medicine, Royal Perth Hospital, Perth, Australia"},{"name":"St John of God Hospital, Subiaco, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna","family":"Boddu","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia and Pain Medicine, Royal Perth Hospital, Perth, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen G","family":"Archer","sequence":"additional","affiliation":[{"name":"St John of God Hospital, Subiaco, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2021,1,27]]},"reference":[{"key":"bibr1-0310057X20973046","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.161460"},{"key":"bibr2-0310057X20973046","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-012-8300-8"},{"key":"bibr3-0310057X20973046","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2004.00440.x"},{"key":"bibr4-0310057X20973046","doi-asserted-by":"crossref","unstructured":"McCleskey PE. Dermatitis to FD&C yellow no. 6 dye in orange antiseptic solution.\n                      Arch Dermatol\n                      2011; 147: 1124-1125.","DOI":"10.1001\/archdermatol.2011.245"},{"key":"bibr5-0310057X20973046","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2011.01936.x"},{"key":"bibr6-0310057X20973046","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2018.04.014"},{"key":"bibr7-0310057X20973046","unstructured":"Yiannias J. Clinical features and diagnosis of allergic contact dermatitis, https:\/\/www.uptodate.com\/contents\/clinical-features-and-diagnosis-of-allergic-contact-dermatitis (accessed 1 November 2020)."},{"key":"bibr8-0310057X20973046","unstructured":"Gaspari A. Basic mechanisms and pathophysiology of allergic contact dermatitis, https:\/\/www.uptodate.com\/contents\/basic-mechanisms-and-pathophysiology-of-allergic-contact-dermatitis?search=basic-mechanisms-andpathophysiology-of-allergic-contact-dermatitis (accessed 1 November 2020)."},{"key":"bibr9-0310057X20973046","unstructured":"European Chemicals Agency. Disodium 6-hydroxy-5-[(2-methoxy-4-sulphonato-m-tolyl)azo]naphthalene-2-sulphonate, https:\/\/echa.europa.eu\/cs\/registration-dossier\/-\/registered-dossier\/12184\/7\/4\/1 (accessed 1 November 2020)."},{"key":"bibr10-0310057X20973046","unstructured":"World Health Organization. Safety evaluation of certain food additives: prepared by the eighty-second meeting of the Joint FAO\/WHO Expert Committee on Food Additives (JECFA), https:\/\/apps.who.int\/iris\/handle\/10665\/258934 (accessed 1 November 2020)."},{"key":"bibr11-0310057X20973046","unstructured":"National Library of Medicine. Compound summary azo fuchsine, https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/19116#section=GHS-Classification (accessed 1 November 2020)."},{"key":"bibr12-0310057X20973046","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.14164","volume":"173","author":"Paul M","year":"2015","journal-title":"Br J Dermatol"},{"key":"bibr13-0310057X20973046","unstructured":"European Chemicals Agency. Summary of Classification and Labelling, https:\/\/echa.europa.eu\/cs\/information-on-chemicals\/cl-inventory-database\/-\/discli\/details\/130312 (accessed 1 November 2020)."},{"key":"bibr14-0310057X20973046","doi-asserted-by":"crossref","unstructured":"Brod BA. Management of allergic contact dermatitis, https:\/\/www.uptodate.com\/contents\/management-of-allergic-contact-dermatitis (accessed 1 November 2020).","DOI":"10.1002\/9781119405702.ch1"}],"container-title":["Anaesthesia and Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0310057X20973046","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0310057X20973046","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0310057X20973046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:11:32Z","timestamp":1777367492000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0310057X20973046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1177\/0310057X20973046"],"URL":"https:\/\/doi.org\/10.1177\/0310057x20973046","relation":{},"ISSN":["0310-057X","1448-0271"],"issn-type":[{"value":"0310-057X","type":"print"},{"value":"1448-0271","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}